A Machine Learning Approach to Predict Cognitive Decline in Alzheimer Disease Clinical Trials

Our results indicate that predictive models have the potential to improve the design of AD trials through selective inclusion and exclusion criteria based on expected cognitive decline. Such predictive models need further validation across data from different AD clinical trials.